Intracellular delivery of mitomycin c with targeted polysaccharide conjugates against multidrug resistance

Annals of Biomedical Engineering

Volumn 39, Issue 9, 2011, Pages 2456-2465

  Cao, Yu ^a   Chen, Didi ^a   Zhao, Peiguang ^a   Liu, Lina ^a   Huang, Xueying ^a   Qi, Chao ^a   Liu, Yanli ^a   He, Hongxuan ^b   Wang, Qian ^a   Liu, Yang ^a   Chen, Sha ^a  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

Drug resistance; Hepatoma targeting; Intracellular drug delivery; Polymeric conjugates

Indexed keywords

DRUG RESISTANCE; HEPATOCYTES; HEPATOMA-TARGETING; HEPG2 CELLS; HUMAN TUMORS; IN-VITRO; INTRACELLULAR DELIVERY; INTRACELLULAR DRUG DELIVERY; MITOMYCIN C; MULTIDRUG RESISTANCE; NON-TARGETED; NUDE MICE; POLYMERIC CONJUGATES; PRODRUGS; THERAPEUTIC EFFECTS; TRANSFER EFFICIENCY; XYLOGLUCANS;

DRUG DELIVERY; MAMMALS;

FUNCTIONAL POLYMERS;

ANTINEOPLASTIC ANTIBIOTIC; GALACTOSAMINE; GLUCAN; MITOMYCIN; PRODRUG; XYLAN; XYLOGLUCAN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL STRAIN HEPG2; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MOUSE; MULTIDRUG RESISTANCE; NUDE MOUSE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GALACTOSAMINE; GLUCANS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOMYCIN; PRODRUGS; XENOGRAFT MODEL ANTITUMOR ASSAYS; XYLANS;

EID: 80051546328     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-011-0333-2     Document Type: Article

References (22)

1. M Breunig S Bauer A Goefferich 2008 Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68 112 128 17804211 10.1016/j.ejpb.2007.06.010 1:CAS:528:DC%2BD2sXhsVSgtb3O (Pubitemid 350181412)
2. T Coviello P Matricardi F Alhaique 2006 Drug delivery strategies using polysaccharidic gels Expert Opin. Drug Deliv. 3 395 404 16640499 10.1517/17425247.3.3.395 1:CAS:528:DC%2BD28Xkt12gsLc%3D (Pubitemid 43772714)
3. A De Marre H Soyez E Schacht MA Shoaibi LW Seymour B Rihova 1995 Synthesis and evaluation of macromolecular prodrugs of mitomycin C J. Control. Release 36 87 97 10.1016/0168-3659(95)00058-G 1:CAS:528:DyaK2MXotVartLY%3D
4. AEH de Mendoza MA Campanero F Mollinedo MJ Blanco-Prieto 2009 Lipid nanomedicines for anticancer drug therapy J. Biomed. Nanotechnol. 5 323 343 10.1166/jbn.2009.1042
5. L Dong SY Gao HJ Diao JN Chen JF Zhang 2008 Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo J. Biomed. Mater. Res. A 84A 777 784 10.1002/jbm.a.31328 1:CAS:528:DC%2BD1cXitFWrtr0%3D (Pubitemid 351237795)
6. R Duncan J Kopecek P Rejmanová JB Lloyd 1983 Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues Biochim. Biophys. Acta 755 518 521 6824743 1:CAS:528:DyaL3sXhs1Krs74%3D (Pubitemid 13146760)
7. K Hoste K De Winne E Schacht 2004 Polymeric prodrugs Int. J. Pharm. 277 119 131 15158975 10.1016/j.ijpharm.2003.07.016 1:CAS:528:DC%2BD2cXktFOitrw%3D (Pubitemid 38670427)
8. K Hoste E Schacht B Rihova 2002 Synthesis and biological evaluation of PEG-substituted macromolecular prodrugs of mitomycin C J. Bioactive Compat. Polym. 17 123 138 10.1106/088391102024443 1:CAS:528:DC%2BD38Xlt1Cnurk%3D (Pubitemid 34602872)
9. NT Huynh C Passirani P Saulnier JP Benoit 2009 Lipid nanocapsules: a new platform for nanomedicine Int. J. Pharm. 379 201 209 19409468 10.1016/j.ijpharm.2009.04.026 1:CAS:528:DC%2BD1MXhtVKjsr%2FF
10. LS Jabr-Milane LE van Vlerken S Yadav MM Amiji 2008 Multi-functional nanocarriers to overcome tumor drug resistance Cancer Treat. Rev. 34 592 602 18538481 10.1016/j.ctrv.2008.04.003 1:CAS:528:DC%2BD1cXht1KgtrvP
11. KA Janes MP Fresneau A Marazuela A Fabra MJ Alonso 2001 Chitosan nanoparticles as delivery systems for doxorubicin J. Control. Release 73 255 267 11516503 10.1016/S0168-3659(01)00294-2 1:CAS:528:DC%2BD3MXksVSqur0%3D (Pubitemid 32539254)
12. K Kunath A von Harpe D Fischer T Kissel 2003 Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency J. Control. Release 88 159 172 12586513 10.1016/S0168-3659(02)00458-3 1:CAS:528:DC%2BD3sXpvF2msA%3D%3D (Pubitemid 36173961)
13. A Mishra AV Malhotra 2009 Tamarind xyloglucan: a polysaccharide with versatile application potential J. Mater. Chem. 19 8528 8536 10.1039/b911150f 1:CAS:528:DC%2BD1MXhtlygu73F
14. A Murao M Nishikawa C Managit J Wong S Kawakami F Yamashita M Hashida 2002 Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition Pharm. Res. 19 1808 1814 12523658 10.1023/A:1021433206081 1:CAS:528:DC%2BD38XpsVSjsLs%3D (Pubitemid 36016026)
15. K Na T Bum Lee KH Park EK Shin YB Lee HK Choi 2003 Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system Eur. J. Pharm. Sci. 18 165 173 12594010 10.1016/S0928-0987(02)00257-9 1:CAS:528:DC%2BD3sXht1Klt70%3D (Pubitemid 36184755)
16. M Nichifor G Mocanu 2006 Polysaccharide-drug conjugates as controlled drug delivery systems Polysacch. Drug Deliv. Pharm. Appl. 934 289 303 10.1021/bk-2006-0934.ch015 1:CAS:528:DC%2BD28XnvFWktb0%3D
17. C Pinto Reis RJ Neufeld J Antonio F Veiga 2006 Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles Nanomed. Nanotechnol. Biol. Med. 2 8 21 10.1016/j.nano.2005.12.003
18. M Sletmoen G Maurstad BT Stokke 2008 Potentials of bionanotechnology in the study and manufacturing of self-assembled biopolymer complexes and gels Food Hydrocoll. 22 2 11 10.1016/j.foodhyd.2006.12.015 1:CAS:528:DC%2BD2sXnsVSqsr4%3D (Pubitemid 47002047)
19. F Suisha N Kawasaki S Miyazaki M Shirakawa K Yamatoya M Sasaki D Attwood 1998 Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C Int. J. Pharm. 172 27 32 10.1016/S0378-5173(98) 00157-4 1:CAS:528:DyaK1cXls1equrs%3D (Pubitemid 28430242)
20. MJ Vicent R Duncan 2006 Polymer conjugates: nanosized medicines for treating cancer Trends Biotechnol. 24 39 47 16307811 10.1016/j.tibtech.2005.11. 006 1:CAS:528:DC%2BD28XitFCrtw%3D%3D (Pubitemid 43017749)
21. SW Warmann J Fuchs 2007 Drug resistance in hepatoblastoma Curr. Pharm. Biotechnol. 8 93 97 17430157 10.2174/138920107780487456 1:CAS:528: DC%2BD2sXls1ygtLk%3D (Pubitemid 46711700)
22. XZ Wu 2008 New strategy of antiangiogenic therapy for hepatocellular carcinoma Minireview Neoplasma 55 472 481 18999874 1:CAS:528: DC%2BD1MXhtFyitb4%3D